img

Global Veterinary Biological Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Veterinary Biological Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether. In this report, we study the vaccine used for animals.
Veterinary Biological Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Veterinary Biological Vaccines market is projected to reach US$ 7288.4 million in 2029, increasing from US$ 5027.1 million in 2022, with the CAGR of 5.9% during the period of 2024 to 2029. Demand from Livestock and Swine are the major drivers for the industry.
According to Our PET Supplies Research Center, the global pet industry reached $ 261 billion in 2022, a year-on-year increase of 11.3%. The United States gains the highest pet penetration rate and becomes the largest pet market. According to the American Pet Products Association (APPA), 66% of American households keep pets, and the total industry sales was about US$136.8 billion, an increase of 10.8% over 2021. According to IVH, the German pet products industry association, the number of pets in Germany reached 33.4 million in 2022, with a total turnover of nearly €6.5 billion. The 2024 China Pet Industry Trend Insight White Paper released by JD shows that the market size of the four major pet physical commodities is increasing year by yearpet supplies account for 45%, pet staple food accounts for nearly 35%, pet snacks account for 12%, and pet medicine and health care account for 551%.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Veterinary Biological Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Yebio
DHN
WINSUN
Elanco
Virbac
CAVAC
Kyoto Biken Laboratories
FATRO
Vaksindo
Bio-Labs
Avimex Animal Health
MEVAC
Biovac
Atafen
Dyntec
Ringpu Biology
Jinyu Bio-technology
Jinhe Biotechnology
China Animal Husbandry Industry
Wuhan Keqian Biology
Pulike Biological Engineering
Chengdu Kanghua Biological Products
Segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Others

Segment by Application


Livestock
Swine
Chicken
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Veterinary Biological Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Veterinary Biological Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Veterinary Biological Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Veterinary Biological Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Veterinary Biological Vaccines introduction, etc. Veterinary Biological Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Veterinary Biological Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Veterinary Biological Vaccines Market Overview
1.1 Veterinary Biological Vaccines Product Overview
1.2 Veterinary Biological Vaccines Market Segment by Type
1.2.1 Live Attenuated Vaccines
1.2.2 Inactivated Vaccines
1.2.3 Others
1.3 Global Veterinary Biological Vaccines Market Size by Type
1.3.1 Global Veterinary Biological Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Veterinary Biological Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Veterinary Biological Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Veterinary Biological Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Veterinary Biological Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Veterinary Biological Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Veterinary Biological Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Veterinary Biological Vaccines Sales Breakdown by Type (2018-2024)
2 Global Veterinary Biological Vaccines Market Competition by Company
2.1 Global Top Players by Veterinary Biological Vaccines Sales (2018-2024)
2.2 Global Top Players by Veterinary Biological Vaccines Revenue (2018-2024)
2.3 Global Top Players by Veterinary Biological Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Veterinary Biological Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Veterinary Biological Vaccines Market Competitive Situation and Trends
2.5.1 Veterinary Biological Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Veterinary Biological Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Biological Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Veterinary Biological Vaccines Market
2.8 Key Manufacturers Veterinary Biological Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Veterinary Biological Vaccines Status and Outlook by Region
3.1 Global Veterinary Biological Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Veterinary Biological Vaccines Historic Market Size by Region
3.2.1 Global Veterinary Biological Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Veterinary Biological Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Veterinary Biological Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Veterinary Biological Vaccines Forecasted Market Size by Region
3.3.1 Global Veterinary Biological Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Veterinary Biological Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Veterinary Biological Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Veterinary Biological Vaccines by Application
4.1 Veterinary Biological Vaccines Market Segment by Application
4.1.1 Livestock
4.1.2 Swine
4.1.3 Chicken
4.1.4 Others
4.2 Global Veterinary Biological Vaccines Market Size by Application
4.2.1 Global Veterinary Biological Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Veterinary Biological Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Veterinary Biological Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Veterinary Biological Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Veterinary Biological Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Veterinary Biological Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Veterinary Biological Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Veterinary Biological Vaccines Sales Breakdown by Application (2018-2024)
5 North America Veterinary Biological Vaccines by Country
5.1 North America Veterinary Biological Vaccines Historic Market Size by Country
5.1.1 North America Veterinary Biological Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Veterinary Biological Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Veterinary Biological Vaccines Sales in Value by Country (2018-2024)
5.2 North America Veterinary Biological Vaccines Forecasted Market Size by Country
5.2.1 North America Veterinary Biological Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Veterinary Biological Vaccines Sales in Value by Country (2024-2029)
6 Europe Veterinary Biological Vaccines by Country
6.1 Europe Veterinary Biological Vaccines Historic Market Size by Country
6.1.1 Europe Veterinary Biological Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Veterinary Biological Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Veterinary Biological Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Veterinary Biological Vaccines Forecasted Market Size by Country
6.2.1 Europe Veterinary Biological Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Veterinary Biological Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Veterinary Biological Vaccines by Region
7.1 Asia-Pacific Veterinary Biological Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Veterinary Biological Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Veterinary Biological Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Veterinary Biological Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Veterinary Biological Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Veterinary Biological Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Veterinary Biological Vaccines Sales in Value by Region (2024-2029)
8 Latin America Veterinary Biological Vaccines by Country
8.1 Latin America Veterinary Biological Vaccines Historic Market Size by Country
8.1.1 Latin America Veterinary Biological Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Veterinary Biological Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Veterinary Biological Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Veterinary Biological Vaccines Forecasted Market Size by Country
8.2.1 Latin America Veterinary Biological Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Veterinary Biological Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Veterinary Biological Vaccines by Country
9.1 Middle East and Africa Veterinary Biological Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Veterinary Biological Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Veterinary Biological Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Veterinary Biological Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Veterinary Biological Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Veterinary Biological Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Veterinary Biological Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Merck Veterinary Biological Vaccines Products Offered
10.1.5 Merck Recent Development
10.2 Zoetis
10.2.1 Zoetis Company Information
10.2.2 Zoetis Introduction and Business Overview
10.2.3 Zoetis Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Zoetis Veterinary Biological Vaccines Products Offered
10.2.5 Zoetis Recent Development
10.3 Boehringer Ingelheim
10.3.1 Boehringer Ingelheim Company Information
10.3.2 Boehringer Ingelheim Introduction and Business Overview
10.3.3 Boehringer Ingelheim Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Boehringer Ingelheim Veterinary Biological Vaccines Products Offered
10.3.5 Boehringer Ingelheim Recent Development
10.4 Ceva
10.4.1 Ceva Company Information
10.4.2 Ceva Introduction and Business Overview
10.4.3 Ceva Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Ceva Veterinary Biological Vaccines Products Offered
10.4.5 Ceva Recent Development
10.5 CAHIC
10.5.1 CAHIC Company Information
10.5.2 CAHIC Introduction and Business Overview
10.5.3 CAHIC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 CAHIC Veterinary Biological Vaccines Products Offered
10.5.5 CAHIC Recent Development
10.6 HVRI
10.6.1 HVRI Company Information
10.6.2 HVRI Introduction and Business Overview
10.6.3 HVRI Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 HVRI Veterinary Biological Vaccines Products Offered
10.6.5 HVRI Recent Development
10.7 Yebio
10.7.1 Yebio Company Information
10.7.2 Yebio Introduction and Business Overview
10.7.3 Yebio Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Yebio Veterinary Biological Vaccines Products Offered
10.7.5 Yebio Recent Development
10.8 DHN
10.8.1 DHN Company Information
10.8.2 DHN Introduction and Business Overview
10.8.3 DHN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 DHN Veterinary Biological Vaccines Products Offered
10.8.5 DHN Recent Development
10.9 WINSUN
10.9.1 WINSUN Company Information
10.9.2 WINSUN Introduction and Business Overview
10.9.3 WINSUN Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 WINSUN Veterinary Biological Vaccines Products Offered
10.9.5 WINSUN Recent Development
10.10 Elanco
10.10.1 Elanco Company Information
10.10.2 Elanco Introduction and Business Overview
10.10.3 Elanco Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Elanco Veterinary Biological Vaccines Products Offered
10.10.5 Elanco Recent Development
10.11 Virbac
10.11.1 Virbac Company Information
10.11.2 Virbac Introduction and Business Overview
10.11.3 Virbac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Virbac Veterinary Biological Vaccines Products Offered
10.11.5 Virbac Recent Development
10.12 CAVAC
10.12.1 CAVAC Company Information
10.12.2 CAVAC Introduction and Business Overview
10.12.3 CAVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.12.4 CAVAC Veterinary Biological Vaccines Products Offered
10.12.5 CAVAC Recent Development
10.13 Kyoto Biken Laboratories
10.13.1 Kyoto Biken Laboratories Company Information
10.13.2 Kyoto Biken Laboratories Introduction and Business Overview
10.13.3 Kyoto Biken Laboratories Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Kyoto Biken Laboratories Veterinary Biological Vaccines Products Offered
10.13.5 Kyoto Biken Laboratories Recent Development
10.14 FATRO
10.14.1 FATRO Company Information
10.14.2 FATRO Introduction and Business Overview
10.14.3 FATRO Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.14.4 FATRO Veterinary Biological Vaccines Products Offered
10.14.5 FATRO Recent Development
10.15 Vaksindo
10.15.1 Vaksindo Company Information
10.15.2 Vaksindo Introduction and Business Overview
10.15.3 Vaksindo Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Vaksindo Veterinary Biological Vaccines Products Offered
10.15.5 Vaksindo Recent Development
10.16 Bio-Labs
10.16.1 Bio-Labs Company Information
10.16.2 Bio-Labs Introduction and Business Overview
10.16.3 Bio-Labs Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Bio-Labs Veterinary Biological Vaccines Products Offered
10.16.5 Bio-Labs Recent Development
10.17 Avimex Animal Health
10.17.1 Avimex Animal Health Company Information
10.17.2 Avimex Animal Health Introduction and Business Overview
10.17.3 Avimex Animal Health Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Avimex Animal Health Veterinary Biological Vaccines Products Offered
10.17.5 Avimex Animal Health Recent Development
10.18 MEVAC
10.18.1 MEVAC Company Information
10.18.2 MEVAC Introduction and Business Overview
10.18.3 MEVAC Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.18.4 MEVAC Veterinary Biological Vaccines Products Offered
10.18.5 MEVAC Recent Development
10.19 Biovac
10.19.1 Biovac Company Information
10.19.2 Biovac Introduction and Business Overview
10.19.3 Biovac Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Biovac Veterinary Biological Vaccines Products Offered
10.19.5 Biovac Recent Development
10.20 Atafen
10.20.1 Atafen Company Information
10.20.2 Atafen Introduction and Business Overview
10.20.3 Atafen Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Atafen Veterinary Biological Vaccines Products Offered
10.20.5 Atafen Recent Development
10.21 Dyntec
10.21.1 Dyntec Company Information
10.21.2 Dyntec Introduction and Business Overview
10.21.3 Dyntec Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Dyntec Veterinary Biological Vaccines Products Offered
10.21.5 Dyntec Recent Development
10.22 Ringpu Biology
10.22.1 Ringpu Biology Company Information
10.22.2 Ringpu Biology Introduction and Business Overview
10.22.3 Ringpu Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Ringpu Biology Veterinary Biological Vaccines Products Offered
10.22.5 Ringpu Biology Recent Development
10.23 Jinyu Bio-technology
10.23.1 Jinyu Bio-technology Company Information
10.23.2 Jinyu Bio-technology Introduction and Business Overview
10.23.3 Jinyu Bio-technology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.23.4 Jinyu Bio-technology Veterinary Biological Vaccines Products Offered
10.23.5 Jinyu Bio-technology Recent Development
10.24 Jinhe Biotechnology
10.24.1 Jinhe Biotechnology Company Information
10.24.2 Jinhe Biotechnology Introduction and Business Overview
10.24.3 Jinhe Biotechnology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.24.4 Jinhe Biotechnology Veterinary Biological Vaccines Products Offered
10.24.5 Jinhe Biotechnology Recent Development
10.25 China Animal Husbandry Industry
10.25.1 China Animal Husbandry Industry Company Information
10.25.2 China Animal Husbandry Industry Introduction and Business Overview
10.25.3 China Animal Husbandry Industry Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.25.4 China Animal Husbandry Industry Veterinary Biological Vaccines Products Offered
10.25.5 China Animal Husbandry Industry Recent Development
10.26 Wuhan Keqian Biology
10.26.1 Wuhan Keqian Biology Company Information
10.26.2 Wuhan Keqian Biology Introduction and Business Overview
10.26.3 Wuhan Keqian Biology Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.26.4 Wuhan Keqian Biology Veterinary Biological Vaccines Products Offered
10.26.5 Wuhan Keqian Biology Recent Development
10.27 Pulike Biological Engineering
10.27.1 Pulike Biological Engineering Company Information
10.27.2 Pulike Biological Engineering Introduction and Business Overview
10.27.3 Pulike Biological Engineering Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.27.4 Pulike Biological Engineering Veterinary Biological Vaccines Products Offered
10.27.5 Pulike Biological Engineering Recent Development
10.28 Chengdu Kanghua Biological Products
10.28.1 Chengdu Kanghua Biological Products Company Information
10.28.2 Chengdu Kanghua Biological Products Introduction and Business Overview
10.28.3 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.28.4 Chengdu Kanghua Biological Products Veterinary Biological Vaccines Products Offered
10.28.5 Chengdu Kanghua Biological Products Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Veterinary Biological Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Veterinary Biological Vaccines Industrial Chain Analysis
11.4 Veterinary Biological Vaccines Market Dynamics
11.4.1 Veterinary Biological Vaccines Industry Trends
11.4.2 Veterinary Biological Vaccines Market Drivers
11.4.3 Veterinary Biological Vaccines Market Challenges
11.4.4 Veterinary Biological Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Veterinary Biological Vaccines Distributors
12.3 Veterinary Biological Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live Attenuated Vaccines
Table 2. Major Company of Inactivated Vaccines
Table 3. Major Company of Others
Table 4. Global Veterinary Biological Vaccines Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Veterinary Biological Vaccines Sales by Type (2018-2024) & (K Units)
Table 6. Global Veterinary Biological Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Veterinary Biological Vaccines Sales by Type (2018-2024) & (US& Million)
Table 8. Global Veterinary Biological Vaccines Market Share in Value by Type (2018-2024)
Table 9. Global Veterinary Biological Vaccines Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Veterinary Biological Vaccines Sales by Type (2024-2029) & (K Units)
Table 11. Global Veterinary Biological Vaccines Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Veterinary Biological Vaccines Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Veterinary Biological Vaccines Sales Market Share in Value by Type (2024-2029)
Table 14. Global Veterinary Biological Vaccines Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Veterinary Biological Vaccines Sales by Type (2018-2024) & (K Units)
Table 16. North America Veterinary Biological Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Veterinary Biological Vaccines Sales (K Units) by Type (2018-2024)
Table 18. Europe Veterinary Biological Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Veterinary Biological Vaccines Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Veterinary Biological Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Veterinary Biological Vaccines Sales (K Units) by Type (2018-2024)
Table 22. Latin America Veterinary Biological Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Veterinary Biological Vaccines Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Veterinary Biological Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Veterinary Biological Vaccines Sales by Company (2018-2024) & (K Units)
Table 26. Global Veterinary Biological Vaccines Sales Share by Company (2018-2024)
Table 27. Global Veterinary Biological Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Veterinary Biological Vaccines Revenue Share by Company (2018-2024)
Table 29. Global Market Veterinary Biological Vaccines Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Veterinary Biological Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Veterinary Biological Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Veterinary Biological Vaccines as of 2022)
Table 33. Date of Key Manufacturers Enter into Veterinary Biological Vaccines Market
Table 34. Key Manufacturers Veterinary Biological Vaccines Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Veterinary Biological Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Veterinary Biological Vaccines Sales by Region (2018-2024) & (K Units)
Table 38. Global Veterinary Biological Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Veterinary Biological Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Veterinary Biological Vaccines Sales Market Share in Value by Region (2018-2024)
Table 41. Global Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Veterinary Biological Vaccines Sales by Region (2024-2029) & (K Units)
Table 43. Global Veterinary Biological Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Veterinary Biological Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Veterinary Biological Vaccines Sales Market Share in Value by Region (2024-2029)
Table 46. Global Veterinary Biological Vaccines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Veterinary Biological Vaccines Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Veterinary Biological Vaccines Sales by Application (2018-2024) & (K Units)
Table 49. Global Veterinary Biological Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Veterinary Biological Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Veterinary Biological Vaccines Sales Market Share in Value by Application (2018-2024)
Table 52. Global Veterinary Biological Vaccines Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Veterinary Biological Vaccines Sales by Application (2024-2029) & (K Units)
Table 54. Global Veterinary Biological Vaccines Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Veterinary Biological Vaccines Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Veterinary Biological Vaccines Sales Market Share in Value by Application (2024-2029)
Table 57. Global Veterinary Biological Vaccines Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Veterinary Biological Vaccines Sales by Application (2018-2024) (K Units)
Table 59. North America Veterinary Biological Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Veterinary Biological Vaccines Sales by Application (2018-2024) (K Units)
Table 61. Europe Veterinary Biological Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Veterinary Biological Vaccines Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Veterinary Biological Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Veterinary Biological Vaccines Sales by Application (2018-2024) (K Units)
Table 65. Latin America Veterinary Biological Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Veterinary Biological Vaccines Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Veterinary Biological Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Veterinary Biological Vaccines Sales by Country (2018-2024) & (K Units)
Table 69. North America Veterinary Biological Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Veterinary Biological Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Veterinary Biological Vaccines Sales Market Share in Value by Country (2018-2024)
Table 72. North America Veterinary Biological Vaccines Sales by Country (2024-2029) & (K Units)
Table 73. North America Veterinary Biological Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Veterinary Biological Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Veterinary Biological Vaccines Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Veterinary Biological Vaccines Sales by Country (2018-2024) & (K Units)
Table 77. Europe Veterinary Biological Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Veterinary Biological Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Veterinary Biological Vaccines Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Veterinary Biological Vaccines Sales by Country (2024-2029) & (K Units)
Table 81. Europe Veterinary Biological Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Veterinary Biological Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Veterinary Biological Vaccines Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Veterinary Biological Vaccines Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Veterinary Biological Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Veterinary Biological Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Veterinary Biological Vaccines Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Veterinary Biological Vaccines Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Veterinary Biological Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Veterinary Biological Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Veterinary Biological Vaccines Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Veterinary Biological Vaccines Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Veterinary Biological Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Veterinary Biological Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Veterinary Biological Vaccines Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Veterinary Biological Vaccines Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Veterinary Biological Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Veterinary Biological Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Veterinary Biological Vaccines Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Veterinary Biological Vaccines Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Veterinary Biological Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Veterinary Biological Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Veterinary Biological Vaccines Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Veterinary Biological Vaccines Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Veterinary Biological Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Veterinary Biological Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Veterinary Biological Vaccines Sales Market Share in Value by Country (2024-2029)
Table 108. Merck Company Information
Table 109. Merck Introduction and Business Overview
Table 110. Merck Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Merck Veterinary Biological Vaccines Product
Table 112. Merck Recent Development
Table 113. Zoetis Company Information
Table 114. Zoetis Introduction and Business Overview
Table 115. Zoetis Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Zoetis Veterinary Biological Vaccines Product
Table 117. Zoetis Recent Development
Table 118. Boehringer Ingelheim Company Information
Table 119. Boehringer Ingelheim Introduction and Business Overview
Table 120. Boehringer Ingelheim Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Boehringer Ingelheim Veterinary Biological Vaccines Product
Table 122. Boehringer Ingelheim Recent Development
Table 123. Ceva Company Information
Table 124. Ceva Introduction and Business Overview
Table 125. Ceva Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Ceva Veterinary Biological Vaccines Product
Table 127. Ceva Recent Development
Table 128. CAHIC Company Information
Table 129. CAHIC Introduction and Business Overview
Table 130. CAHIC Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. CAHIC Veterinary Biological Vaccines Product
Table 132. CAHIC Recent Development
Table 133. HVRI Company Information
Table 134. HVRI Introduction and Business Overview
Table 135. HVRI Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. HVRI Veterinary Biological Vaccines Product
Table 137. HVRI Recent Development
Table 138. Yebio Company Information
Table 139. Yebio Introduction and Business Overview
Table 140. Yebio Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Yebio Veterinary Biological Vaccines Product
Table 142. Yebio Recent Development
Table 143. DHN Company Information
Table 144. DHN Introduction and Business Overview
Table 145. DHN Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. DHN Veterinary Biological Vaccines Product
Table 147. DHN Recent Development
Table 148. WINSUN Company Information
Table 149. WINSUN Introduction and Business Overview
Table 150. WINSUN Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. WINSUN Veterinary Biological Vaccines Product
Table 152. WINSUN Recent Development
Table 153. Elanco Company Information
Table 154. Elanco Introduction and Business Overview
Table 155. Elanco Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Elanco Veterinary Biological Vaccines Product
Table 157. Elanco Recent Development
Table 158. Virbac Company Information
Table 159. Virbac Introduction and Business Overview
Table 160. Virbac Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Virbac Veterinary Biological Vaccines Product
Table 162. Virbac Recent Development
Table 163. CAVAC Company Information
Table 164. CAVAC Introduction and Business Overview
Table 165. CAVAC Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. CAVAC Veterinary Biological Vaccines Product
Table 167. CAVAC Recent Development
Table 168. Kyoto Biken Laboratories Company Information
Table 169. Kyoto Biken Laboratories Introduction and Business Overview
Table 170. Kyoto Biken Laboratories Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 171. Kyoto Biken Laboratories Veterinary Biological Vaccines Product
Table 172. Kyoto Biken Laboratories Recent Development
Table 173. FATRO Company Information
Table 174. FATRO Introduction and Business Overview
Table 175. FATRO Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 176. FATRO Veterinary Biological Vaccines Product
Table 177. FATRO Recent Development
Table 178. Vaksindo Company Information
Table 179. Vaksindo Introduction and Business Overview
Table 180. Vaksindo Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 181. Vaksindo Veterinary Biological Vaccines Product
Table 182. Vaksindo Recent Development
Table 183. Bio-Labs Company Information
Table 184. Bio-Labs Introduction and Business Overview
Table 185. Bio-Labs Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 186. Bio-Labs Veterinary Biological Vaccines Product
Table 187. Bio-Labs Recent Development
Table 188. Avimex Animal Health Company Information
Table 189. Avimex Animal Health Introduction and Business Overview
Table 190. Avimex Animal Health Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 191. Avimex Animal Health Veterinary Biological Vaccines Product
Table 192. Avimex Animal Health Recent Development
Table 193. MEVAC Company Information
Table 194. MEVAC Introduction and Business Overview
Table 195. MEVAC Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 196. MEVAC Veterinary Biological Vaccines Product
Table 197. MEVAC Recent Development
Table 198. Biovac Company Information
Table 199. Biovac Introduction and Business Overview
Table 200. Biovac Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 201. Biovac Veterinary Biological Vaccines Product
Table 202. Biovac Recent Development
Table 203. Atafen Company Information
Table 204. Atafen Introduction and Business Overview
Table 205. Atafen Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 206. Atafen Veterinary Biological Vaccines Product
Table 207. Atafen Recent Development
Table 208. Dyntec Company Information
Table 209. Dyntec Introduction and Business Overview
Table 210. Dyntec Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 211. Dyntec Veterinary Biological Vaccines Product
Table 212. Dyntec Recent Development
Table 213. Ringpu Biology Company Information
Table 214. Ringpu Biology Introduction and Business Overview
Table 215. Ringpu Biology Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 216. Ringpu Biology Veterinary Biological Vaccines Product
Table 217. Ringpu Biology Recent Development
Table 218. Jinyu Bio-technology Company Information
Table 219. Jinyu Bio-technology Introduction and Business Overview
Table 220. Jinyu Bio-technology Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 221. Jinyu Bio-technology Veterinary Biological Vaccines Product
Table 222. Jinyu Bio-technology Recent Development
Table 223. Jinhe Biotechnology Company Information
Table 224. Jinhe Biotechnology Introduction and Business Overview
Table 225. Jinhe Biotechnology Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 226. Jinhe Biotechnology Veterinary Biological Vaccines Product
Table 227. Jinhe Biotechnology Recent Development
Table 228. China Animal Husbandry Industry Introduction and Business Overview
Table 229. China Animal Husbandry Industry Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 230. China Animal Husbandry Industry Veterinary Biological Vaccines Product
Table 231. China Animal Husbandry Industry Recent Development
Table 232. China Animal Husbandry Industry Company Information
Table 233. Wuhan Keqian Biology Company Information
Table 234. Wuhan Keqian Biology Introduction and Business Overview
Table 235. Wuhan Keqian Biology Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 236. Wuhan Keqian Biology Veterinary Biological Vaccines Product
Table 237. Wuhan Keqian Biology Recent Development
Table 238. Pulike Biological Engineering Company Information
Table 239. Pulike Biological Engineering Introduction and Business Overview
Table 240. Pulike Biological Engineering Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 241. Pulike Biological Engineering Veterinary Biological Vaccines Product
Table 242. Pulike Biological Engineering Recent Development
Table 243. Chengdu Kanghua Biological Products Company Information
Table 244. Chengdu Kanghua Biological Products Introduction and Business Overview
Table 245. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 246. Chengdu Kanghua Biological Products Veterinary Biological Vaccines Product
Table 247. Chengdu Kanghua Biological Products Recent Development
Table 248. Key Raw Materials Lists
Table 249. Raw Materials Key Suppliers Lists
Table 250. Veterinary Biological Vaccines Market Trends
Table 251. Veterinary Biological Vaccines Market Drivers
Table 252. Veterinary Biological Vaccines Market Challenges
Table 253. Veterinary Biological Vaccines Market Restraints
Table 254. Veterinary Biological Vaccines Distributors List
Table 255. Veterinary Biological Vaccines Downstream Customers
Table 256. Research Programs/Design for This Report
Table 257. Key Data Information from Secondary Sources
Table 258. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Biological Vaccines Product Picture
Figure 2. Global Veterinary Biological Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Veterinary Biological Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Veterinary Biological Vaccines Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Live Attenuated Vaccines
Figure 6. Global Live Attenuated Vaccines Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Inactivated Vaccines
Figure 8. Global Inactivated Vaccines Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Others
Figure 10. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Veterinary Biological Vaccines Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Veterinary Biological Vaccines Sales Market Share by Type in 2022 & 2029
Figure 13. North America Veterinary Biological Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. North America Veterinary Biological Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Europe Veterinary Biological Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Europe Veterinary Biological Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Veterinary Biological Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Veterinary Biological Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Latin America Veterinary Biological Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Veterinary Biological Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Veterinary Biological Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Veterinary Biological Vaccines Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Biological Vaccines Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Veterinary Biological Vaccines Revenue in 2022
Figure 25. Veterinary Biological Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Livestock
Figure 27. Global Livestock Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Swine
Figure 29. Global Swine Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Chicken
Figure 31. Global Chicken Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Veterinary Biological Vaccines Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Veterinary Biological Vaccines Sales Market Share by Application in 2022 & 2029
Figure 36. North America Veterinary Biological Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. North America Veterinary Biological Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Europe Veterinary Biological Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Europe Veterinary Biological Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Veterinary Biological Vaccines Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Veterinary Biological Vaccines Sales Market Share in Value by Application in 2022
Figure 42. Latin America Veterinary Biological Vaccines Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Veterinary Biological Vaccines Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Veterinary Biological Vaccines Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Veterinary Biological Vaccines Manufacturing Cost Structure
Figure 47. Veterinary Biological Vaccines Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries